GRI Bio (GRI) Profit After Tax (2020 - 2026)

GRI Bio's Profit After Tax history runs 7 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 34.41% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$10.9 million (down 16.45% YoY), while the FY2025 annual figure was -$12.0 million, down 45.68% from the prior year.
• Profit After Tax for Q1 2026 stood at -$2.0 million, up from -$2.7 million in the prior quarter.
• The five-year high for Profit After Tax was -$295000.0 in Q2 2022, with the low at -$6.7 million in Q2 2023.
• The 5-year median for Profit After Tax is -$2.1 million (2023), against an average of -$2.3 million.
• The sharpest annual moves came in 2022 and 2023: Profit After Tax soared 88.55% in 2022, then plunged 2186.78% in 2023.
• GRI Bio's Profit After Tax stood at -$2.3 million in 2022, then increased by 11.68% to -$2.0 million in 2023, then gained by 2.79% to -$1.9 million in 2024, then plunged by 36.5% to -$2.7 million in 2025, then grew by 24.86% to -$2.0 million in 2026.
• Business Quant data shows GRI's Profit After Tax at -$2.0 million in Q1 2026, -$2.7 million in Q4 2025, and -$3.4 million in Q3 2025.